Chemmedchem

Journal Title：Chemmedchem

Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies.

ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs.

Contents

ChemMedChem publishes an attractive mixture of:

Full Papers and Communications

Reviews and Minireviews

Patent Reviews

Highlights and Concepts

Book and Multimedia Reviews.

质量研究。优秀的出版物。 ChemMedChem 的影响因子为 3.124 (2019)，是化学、生物学和医学交叉领域研究的顶级期刊。它是代表欧洲化学协会出版的，该协会由 16 个欧洲化学学会组成。

ChemMedChem 为世界各地的作者发布主要以及重要的次要和三级信息。它的使命是整合广泛而蓬勃发展的医学和制药科学领域，从药物设计和发现到药物开发和交付，从分子建模到组合化学，从目标验证到先导生成和 ADMET 研究。 ChemMedChem 通常涵盖小分子、治疗性大分子、肽、肽模拟物和适体、蛋白质-药物偶联物、核酸疗法，以及从 2017 年开始的纳米医学，特别是 1) 靶向纳米递送、2) 治疗诊断纳米粒子和 3) 纳米药物。 /p>

内容

ChemMedChem 发布了一个有吸引力的组合：

完整的论文和通讯

评论和迷你评论

专利审查

亮点和概念

图书和多媒体评论。

Chemmedchem创刊于2006年，由WILEY-V C H VERLAG GMBH出版商出版，收稿方向涵盖医学 - 药学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度约1.0个月，影响因子指数3.124，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。